Table 1.

Insulin, glucagon, lipids, and troponin measurements. Plasma samples taken at 20 weeks for metabolic analyses showed there were no significant differences (P > 0.05) in insulin, glucagon, lipids, and troponin measurements in RGZ- and dexamethasone-treated groups compared with controls. Values are mean ± SD. N = 24 (6 in each group).

Treatment group	Insulin (ng/mL)	Glucagon (pg/mL)	Triglycerides (mg/dL)	Cholesterol (mg/dL)	Troponin (ng/mL)
Control	2.3 ± 1.7	217.3 ± 12	33.2 ± 15	94.4 ± 15	0.18 ± 0.18
RGZ 0.3 mg/kg	2.6 ± 1.4	190.6 ± 6	35.6 ± 6	105.1 ± 15	0.16 ± 0.23
RGZ 3 mg/kg	2.7 ± 0.9	208.2 ± 23	32.5 ± 23	108.9 ± 14	0.10 ± 0.08
Dexamethasone 0.25 mg/kg	2.3 ± 1.4	207.8 ± 13	30.3 ± 13	95.8 ± 21	0.13 ± 0.13